Vedanta Limited Announces Vesting of 2022 Stock Options and New Performance-Based Grants
Vedanta Limited's NRC approved the vesting of 46.91 lakh stock options from 2022 grants and new performance-based grants of 97.80 lakh options to eligible employees, with an exercise price of ₹1.
The impact is medium as it pertains to employee compensation and retention, and involves potential future equity dilution. While not a major capital event, it affects employee motivation and future share count.
The announcement of vesting and new stock option grants is generally positive as it aligns employee interests with the company's performance, incentivizes retention, and rewards past achievements.
* The Nomination and Remuneration Committee (NRC) of Vedanta Limited, in a meeting held on October 31, 2025, approved the vesting of Employee Stock Option Grants 2022 and new performance-based grants. * Vesting of 2022 Employee Stock Option Grants: * Options granted in 2022, on completion of the performance period and achievement of performance conditions, have vested. * Total options granted were 1,47,66,707 equity shares, with 46,91,300 equity shares (each convertible into 1 equity share of face value ₹1/- each) now vested. * The exercise price for these options is ₹1 (par value). * The vested options may be exercised within 8 months or such other time period approved by the NRC. * Performance-based Grants: * The NRC approved the grant of 97,80,400 stock options to eligible employees, including Key Managerial Personnel and Senior Management. * Each option is convertible into 1 equity share of face value ₹1 each. * The exercise price is ₹1 (par value). * These options will vest 36 months from the grant date, subject to achievement of performance conditions. * Options may be exercised within 8 months from the date of vesting. * Both the vesting and new grants are in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
What to do with a filing like this
Vedanta Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vedanta Limited. Read the original for the full detail.